ProfileGDS5678 / 1436581_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 57% 54% 57% 66% 58% 57% 59% 57% 56% 59% 63% 58% 60% 58% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5119757
GSM967853U87-EV human glioblastoma xenograft - Control 23.348954
GSM967854U87-EV human glioblastoma xenograft - Control 33.4586757
GSM967855U87-EV human glioblastoma xenograft - Control 43.9574266
GSM967856U87-EV human glioblastoma xenograft - Control 53.4416958
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.532657
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.6340659
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4757
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4070956
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.5337459
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.7848263
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4850858
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.5830560
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.5000758